Janielle P Maynard

11PUBLICATIONS
53CO-AUTHORS
Immunogenetics (incl. genetic immunology)Predictive and prognostic markersHaematological tumoursMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 01, 2026
HLA Class I Expression Is Associated with Increased Immune Cell Density and PTEN Loss in Prostate Cancer.

|Oct 10, 2024
P2 purinergic receptor expression and function in tumor-related immune cells.

Vahinipriya Manoharan, Oluwafemi O Adegbayi, Janielle P Maynard

|Sep 12, 2023
P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortality.

Athis R Arunachalam, Sanju S Samuel, Arunmani Mani

|Aug 16, 2022
Localization of macrophage subtypes and neutrophils in the prostate tumor microenvironment and their association with prostate cancer racial disparities.

Janielle P Maynard, Taylor N Godwin, Jiayun Lu

|Jun 10, 2022
P2 purinergic receptor dysregulation in urologic disease.

Janielle P Maynard, Karen S Sfanos

|Oct 15, 2021
P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer.

Janielle P Maynard, Jiayun Lu, Igor Vidal

Pageof 2

Frequent Collaborators

6 joint publications

Karen Sfanos

5 joint publications

Angelo M De Marzo

4 joint publications

Tamara L Lotan

2 joint publications

Ibrahim Kulac